DNA Repair in Prostate Cancer: Biology and Clinical Implications

Slides:



Advertisements
Similar presentations
Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:
Advertisements

Non Homologous End Joining. Homologous Recombination Non Homologous End Joining.
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
HR=homologous recombination
Volume 60, Issue 2, Pages (August 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
David Lorente, Karim Fizazi, Christopher Sweeney, Johann S. de Bono 
Volume 70, Issue 6, Pages (December 2016)
Targeting the DNA Damage Response in Cancer
Box Mutations in BRCA1/2 and Rad51 are associated with breast cancer
Molecular Biology of Aging
Volume 71, Issue 2, Pages (February 2017)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Genome-editing Technologies for Gene and Cell Therapy
Prostate Cancer Epidemic in Sight?
Felix Dietlein, Lisa Thelen, H. Christian Reinhardt  Trends in Genetics 
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer  Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, Gerhardt Attard, Kim.
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 66, Issue 3, Pages (September 2014)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 6, Pages (June 2016)
Figure 3 Endogenous repair of double-strand DNA breaks
The Mutational Landscape of Prostate Cancer
Oh what a tangled web it weaves: BRCA1 and DNA decatenation
Prostate Cancer Epidemic in Sight?
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Mark A. Rubin, Gabriele Girelli, Francesca Demichelis  European Urology 
Leonard S. Marks, Jiaoti Huang  European Urology 
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
The Lethal Clone in Prostate Cancer: Redefining the Index
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
Origin of Chromosomal Translocations in Lymphoid Cancer
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
Volume 73, Issue 5, Pages (May 2018)
Chapter 14: Mutation & repair
Volume 137, Issue 2, Pages (May 2015)
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Testicular Cancer Variations in Time and Space in Europe
Volume 2, Issue 1, Pages 2-4 (July 2002)
Cancer Genomes Evolve by Pulverizing Single Chromosomes
Genome Science Theme Seminar
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
CRISPR genome-editing: A medical revolution
Felix Y. Feng, Johann S. de Bono, Mark A. Rubin, Karen E. Knudsen 
European Urology is “Your” Journal
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Genome-editing Technologies for Gene and Cell Therapy
Somatic Hypermutation of Immunoglobulin Genes
DNA Double-Strand Breaks Come into Focus
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Fanconi Anemia (Cross)linked to DNA Repair
The role of microhomology in genomic structural variation
A CRISPR Approach to Gene Targeting
DNA repair: Rad52 – the means to an end
Volume 53, Issue 2, Pages (February 2008)
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
At Loose Ends: Resecting a Double-Strand Break
Are Mouse Telomeres Going to Pot?
Volume 51, Issue 5, Pages (May 2007)
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
CRISPR Craze to Transform Cardiac Biology
Presentation transcript:

DNA Repair in Prostate Cancer: Biology and Clinical Implications Joaquin Mateo, Gunther Boysen, Christopher E. Barbieri, Helen E. Bryant, Elena Castro, Pete S. Nelson, David Olmos, Colin C. Pritchard, Mark A. Rubin, Johann S. de Bono  European Urology  Volume 71, Issue 3, Pages 417-425 (March 2017) DOI: 10.1016/j.eururo.2016.08.037 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 An overview of the most important DNA damage–inducing stresses and the corresponding molecular pathways that eukaryotic cells established to repair these. Diverse environmental and endogenous stresses can damage DNA, causing either single-strand (lilac) or double-strand (red box) DNA breaks. Eukaryotic cells developed various molecular mechanisms that repair such damage. DNA double-strand breaks are the most toxic DNA damage, and can be lethal for a cell if not properly repaired. The two most common and best-studied DNA double-strand repair pathways are homologous recombination (HR; error-free) and nonhomologous end-joining (NHEJ; error-prone). HR is limited to the S/G2 phases of the cell cycle and requires a sister chromatid as repair template. Key pathway components are highlighted. NHEJ is active mostly during the G1 phase of the cell cycle and can lead to structural genomic alterations (rearrangements), loss of genomic material (deletion), or insertion of additional nucleotides as a consequence of its imprecise nature. Key pathway components are highlighted. European Urology 2017 71, 417-425DOI: (10.1016/j.eururo.2016.08.037) Copyright © 2016 European Association of Urology Terms and Conditions